Variations of Human Heat Shock Proteins in Multiple Cancers
Xiaoxia Liu,Ka Li,Lingyan Wang,Miaomiao Zhang,Xiangdong Wang
DOI: https://doi.org/10.1002/ctm2.320
IF: 8.554
2021-01-01
Clinical and Translational Medicine
Abstract:Dear Editor, The sensitivity of lung cancer cells to drugs was recently found to be associated with the expression of some heat shock proteins (HSP), of which the heat shock 70 kDa protein 6 (HSPA6) plays a decisive role in cell sensitivity through inter-molecular communications among HSPAs, HSPs, and other signals.1 The major groups of HSPs, classified on basis of the molecular weights, are involved in the regulation of angiogenesis, cell proliferation, migration, invasion, and metastasis.2,3 HSPs may promote cell toxicity and resistance to drugs4,5 and can be used as cancer diagnostic and prognostic biomarkers, as well as therapeutic targets for clinical practice, to represent the specificity of disease, stage, duration, severity, and response to drugs.6–8 In order to furthermore clarify roles of HSPs in cancers, we comprehensively analyzed transcriptomic profiles ofHSP family, e.g. chaperonins, DNAJ (HSP40),HSPA (HSP70), HSPC (HSP90), and HSPB (small HSP), in 9018 patients with 28 cancers. To identify cancer-related HSPs, differentially expressed genes (DEG) of cancer (n = 9018) and normal tissues (n = 5526) were assessed in 28 cancers with P < .05 and fold changes > 1.5 folds. The full frequency of 95 HSPs in databases was 2660 in 28 cancers, while about 46% of HSPs were upand down-regulated in each cancer. This implies that HSP family members actively or passively contribute to the development of cancer. Table 1 demonstrates that more than 40 HSPs were dysregulated in 16 cancers, including squamous cell carcinoma, lymphoma, and gastrointestinal adenocarcinoma. The results showed more than 70% cancer-related HSPs were up-regulated in thymoma (n = 75), diffuse large B-cell lymphoma (DLBC) (n= 74), and pancreatic adenocarcinoma (n= 71), while also about 50% were down-regulated in testicular germ cell tumors (TGCT) (n = 63), and acute myeloid leukemia (n= 60). It seems that dysregulated expression of HSPsmaymainly contribute to leukocyteand epitheliumorigin cancers. Figure 1A demonstrated that HSPA6 was highly down-regulated in thymoma andDLBC,while overexpressed in lung adenocarcinoma (LUAD). The deletion of HSPA6 made lung cancer cells resistant to the ther-